| Literature DB >> 33956071 |
Christopher M Whitford1, Pablo Cruz-Morales2,3,4, Jay D Keasling1,2,3,4,5,6, Tilmann Weber1.
Abstract
Streptomycetes are producers of a wide range of specialized metabolites of great medicinal and industrial importance, such as antibiotics, antifungals, or pesticides. Having been the drivers of the golden age of antibiotics in the 1950s and 1960s, technological advancements over the last two decades have revealed that very little of their biosynthetic potential has been exploited so far. Given the great need for new antibiotics due to the emerging antimicrobial resistance crisis, as well as the urgent need for sustainable biobased production of complex molecules, there is a great renewed interest in exploring and engineering the biosynthetic potential of streptomycetes. Here, we describe the Design-Build-Test-Learn (DBTL) cycle for metabolic engineering experiments in streptomycetes and how it can be used for the discovery and production of novel specialized metabolites.Entities:
Keywords: DBTL; Streptomyces; metabolic engineering; secondary metabolite; specialized metabolite
Mesh:
Substances:
Year: 2021 PMID: 33956071 DOI: 10.1042/EBC20200132
Source DB: PubMed Journal: Essays Biochem ISSN: 0071-1365 Impact factor: 8.000